|Articles|February 15, 2002
Studies to determine if others may benefit from PDT
Cleveland-esearchers hope to expand on the benefits of photodynamic therapy (PDT) for patients with subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD), said Lawrence Singerman, MD
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement














































.png)


